Cardiovascular Medications and Fractures: Dodging Complexity
- PMID: 27893011
- PMCID: PMC5380364
- DOI: 10.1001/jamainternmed.2016.7040
Cardiovascular Medications and Fractures: Dodging Complexity
Comment on
-
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.JAMA Intern Med. 2017 Jan 1;177(1):67-76. doi: 10.1001/jamainternmed.2016.6821. JAMA Intern Med. 2017. PMID: 27893045 Clinical Trial.
References
-
- Perlis AJ. Special Feature: Epigrams on programming. J SIGPLAN Not. 1982;17(9):7–13. - PubMed
-
- Ghosh M, Majumdar SR. Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis. Endocrine. 2014;46(3):397–405. - PubMed
-
- Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study. Journal of Hypertension. 2006;24(3):581–9. - PubMed
-
- Hartikainen S, Lönnroos E, Louhivuori K. Medication as a Risk Factor for Falls: Critical Systematic Review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2007;62(10):1172–81. - PubMed
-
- Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporosis International. 2013;24(10):2649–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
